| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.004 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |